GR1001041B - Μεθοδος για την παρασκευη ενεσιμου διαλυματος. - Google Patents

Μεθοδος για την παρασκευη ενεσιμου διαλυματος.

Info

Publication number
GR1001041B
GR1001041B GR900100795A GR900100795A GR1001041B GR 1001041 B GR1001041 B GR 1001041B GR 900100795 A GR900100795 A GR 900100795A GR 900100795 A GR900100795 A GR 900100795A GR 1001041 B GR1001041 B GR 1001041B
Authority
GR
Greece
Prior art keywords
indole
bis
alkaloid
preparation process
injectable solution
Prior art date
Application number
GR900100795A
Other languages
English (en)
Other versions
GR900100795A (en
Inventor
Nee Zsoldos Monika Bodjak
Maria Dr Ghzdag
Eszter Eva Kiss
Laszlo Nagy
Takcsi Geza Dr Nagy
Gabor Dr Szepesi
Zsofia Pap Nei Sziklai
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of GR900100795A publication Critical patent/GR900100795A/el
Publication of GR1001041B publication Critical patent/GR1001041B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Press Drives And Press Lines (AREA)
  • Press-Shaping Or Shaping Using Conveyers (AREA)
  • Powder Metallurgy (AREA)

Abstract

Η ευρεσιτεχνία αναφέρεται σε μέθοδο παρασκευής παρεντερικώς χρήσιμων σταθερών υδατικών φαρμακευτικών συνθέσεων, κυρίως ενέσιμων διαλυμάτων, που περιέχουν αλκαλοειδές δις-ινδολίου. Οι συνθέσεις περιέχουν το μετά ψευδαργύρου σύμπλοκο του αλκαλοειδούς δις-ινδολίου, κατά προτίμηση βινκριστίνης, βιμπλαστίνης ή 5'-νορ-δι-υδροβιμπλαστίνης, μαζί με γλυκονικό δισθενούς μετάλλου και συντηρητικό διαλελυμένο σε μονο-ή πολυ-υδρική αλκοόλη. Η σύμφωνη με την ευρεσιτεχνία σύνθεση μπορεί να χρησιμοποιηθεί για την παρεντερική χορήγηση αλκαλοειδών δις- ινδολίου στην χημειοθεραπεία του καρκίνου. ω
GR900100795A 1989-11-07 1990-11-07 Μεθοδος για την παρασκευη ενεσιμου διαλυματος. GR1001041B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (2)

Publication Number Publication Date
GR900100795A GR900100795A (en) 1992-04-17
GR1001041B true GR1001041B (el) 1993-03-31

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100795A GR1001041B (el) 1989-11-07 1990-11-07 Μεθοδος για την παρασκευη ενεσιμου διαλυματος.

Country Status (37)

Country Link
US (1) US5397784A (el)
JP (1) JP3042702B2 (el)
KR (1) KR0164601B1 (el)
CN (1) CN1053569C (el)
AR (1) AR245592A1 (el)
AT (1) AT401469B (el)
AU (1) AU638504B2 (el)
BE (1) BE1004051A4 (el)
BG (1) BG60609B1 (el)
CA (1) CA2029368C (el)
CH (1) CH682130A5 (el)
CZ (1) CZ279433B6 (el)
DE (1) DE4035253B4 (el)
DK (1) DK266390A (el)
ES (1) ES2026062A6 (el)
FI (1) FI100455B (el)
FR (1) FR2653998B1 (el)
GB (1) GB2238241B (el)
GR (1) GR1001041B (el)
HU (1) HU204995B (el)
IE (1) IE62387B1 (el)
IL (1) IL96249A (el)
IT (1) IT1242724B (el)
LT (1) LT3334B (el)
LV (1) LV10687B (el)
MY (1) MY104595A (el)
NL (1) NL9002412A (el)
NO (1) NO175565C (el)
NZ (1) NZ236005A (el)
PL (1) PL164881B1 (el)
PT (1) PT95810B (el)
RU (1) RU1828401C (el)
SE (1) SE509715C2 (el)
SK (1) SK540290A3 (el)
UA (1) UA13162A (el)
YU (1) YU48373B (el)
ZA (1) ZA908855B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2002100303A (ja) * 2000-09-20 2002-04-05 Hitachi Ltd カラ−陰極線管
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (zh) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (de) * 1980-07-31 1982-05-12 Uwe Olthoff Verfahren zur herstellung stabiler kalziumhaltiger injektionsloesungen
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Also Published As

Publication number Publication date
SE509715C2 (sv) 1999-03-01
AU6584590A (en) 1991-05-16
SK278421B6 (en) 1997-05-07
GB2238241A (en) 1991-05-29
MY104595A (en) 1994-04-30
CZ540290A3 (en) 1994-11-16
UA13162A (uk) 1997-02-28
KR0164601B1 (ko) 1999-01-15
GB9024222D0 (en) 1990-12-19
IT9067868A1 (it) 1992-05-06
HUT55225A (en) 1991-05-28
CA2029368A1 (en) 1991-05-08
IE62387B1 (en) 1995-01-25
CA2029368C (en) 2000-01-04
ATA223090A (de) 1996-02-15
HU204995B (en) 1992-03-30
NO175565C (no) 1994-11-02
LV10687A (lv) 1995-06-20
FR2653998A1 (fr) 1991-05-10
LTIP512A (en) 1994-11-25
FI905508A0 (fi) 1990-11-07
NO904821D0 (no) 1990-11-06
BG93175A (bg) 1993-12-24
AR245592A1 (es) 1994-02-28
GR900100795A (en) 1992-04-17
IL96249A (en) 1995-07-31
LT3334B (en) 1995-07-25
HU895804D0 (en) 1990-01-28
YU209590A (sh) 1993-05-28
SK540290A3 (en) 1997-05-07
SE9003523D0 (sv) 1990-11-06
JP3042702B2 (ja) 2000-05-22
NO175565B (no) 1994-07-25
DE4035253B4 (de) 2004-10-07
FI100455B (fi) 1997-12-15
YU48373B (sh) 1998-07-10
IT9067868A0 (it) 1990-11-06
AT401469B (de) 1996-09-25
DE4035253A1 (de) 1991-05-08
BE1004051A4 (fr) 1992-09-15
PL164881B1 (en) 1994-10-31
JPH03206040A (ja) 1991-09-09
ES2026062A6 (es) 1992-04-01
DK266390D0 (da) 1990-11-06
DK266390A (da) 1991-05-08
SE9003523L (sv) 1991-05-08
BG60609B1 (bg) 1995-10-31
KR910009245A (ko) 1991-06-28
US5397784A (en) 1995-03-14
IE903993A1 (en) 1991-05-08
LV10687B (en) 1995-12-20
CN1053569C (zh) 2000-06-21
RU1828401C (ru) 1993-07-15
CN1053185A (zh) 1991-07-24
ZA908855B (en) 1991-08-28
IT1242724B (it) 1994-05-17
IL96249A0 (en) 1991-08-16
AU638504B2 (en) 1993-07-01
NL9002412A (nl) 1991-06-03
PT95810A (pt) 1991-09-13
NZ236005A (en) 1992-03-26
PT95810B (pt) 1997-11-28
GB2238241B (en) 1993-10-06
NO904821L (no) 1991-05-08
CH682130A5 (el) 1993-07-30
CZ279433B6 (cs) 1995-04-12
FR2653998B1 (fr) 1995-02-17

Similar Documents

Publication Publication Date Title
ATE31537T1 (de) Peptidderivate mit polyzyklischer stickstoffstruktur, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE108799T1 (de) Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.
PT86810A (pt) Process for preparing stable interferon complexes
KR880012632A (ko) 신규의 2β-모르포리노-안드로스탄 유도체 및 그 제조방법
ES8600264A1 (es) Un procedimiento para la preparacion de nuevos derivados de furanona
GR1001041B (el) Μεθοδος για την παρασκευη ενεσιμου διαλυματος.
ATE105484T1 (de) Aminderivate von folsaeure analogen.
ZA904495B (en) Peptide derivatives,process for preparing them and pharmaceutical compositions containing them
AU4466789A (en) Xanthine derivatives
KR890000482A (ko) (8β)-1-알킬-6-(치환된) 에르 골린의 시클로알킬아미드
AR012826A1 (es) Complejo de bis-platino (ii), metodo para preparar dicho complejo y uso del mismo en la preparacion de una composicion farmaceutica para tratar tumores.
NO175802C (no) Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning
SE8602523D0 (sv) 2-alkyl- eller -aralkyltio-1-cykloalken-1-karboxamider och deras sulfoxider, sett for deras framstellning och deras anvendning for syntes av tri- och 4,5-tetrametylen-4-isotiazolin-3-oner
EP0354778A3 (en) Method for production of dimeric alkaloids
ATE92497T1 (de) Glucuronsaeure-derivate von opioid-antagonisten.
NZ229300A (en) Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
KR890014515A (ko) 트리사이클릭 아민 유도체
GR890100048A (el) Μέ?οδος παρασκευής παραγώγων εργολίνης.
EP0370712A3 (en) Ethylamine derivatives and hypotensives containing the same
GB1384684A (en) 1,3,5-triazine and process for the preparation thereof
TH5618EX (th) อนุพันธุ์อิมิดาโซล
UA18634A1 (uk) Спосіб одердаhhя похідhих l-алаhіл-l-пропіліhа або їх фармацевтичhо прийhятhих солей
KR940701387A (ko) 벤즈이미다졸 유도체, 그의 제조법, 그를 유효성분으로서 함유하는 제토제 및 그의 제조용 중간체
TH5618A (th) อนุพันธุ์อิมิดาโซล

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees